| 摘要 |
FIELD: medicine.SUBSTANCE: present group of inventions refers to medicine, namely therapy, and concerns treating fibrotic diseases. That is ensured by administering 40-O-(2-hydroxy)ethylrapamycin or a pharmaceutical composition thereof in the effective amount.EFFECT: administering the above compound provides slowing of the hepatic fibrosis development, including following liver transplantation with underlying immunosuppressive therapy.3 cl |
